Clinical Trial Update: Effect of Rapamycin in Ovarian Aging [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the effects of rapamycin on ovarian aging in perimenopausal individuals; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perimenopause

Drugs mentioned

• Rapamycin (sirolimus)

Snippet

Sponsor: Columbia University | Conditions: Perimenopausal | Phase 2 | Status: ACTIVE_NOT_RECRUITING